↑Gao L, Tse SW, Conrad C, Andreadis A (Nov 2005). "Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6". J Biol Chem. 280 (47): 39268–72. doi:10.1074/jbc.M506116200. PMID16186110.
Cook L, Brayne CE, Easton D, et al. (2002). "No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease". Ann. Neurol. 52 (5): 690–1. doi:10.1002/ana.10362. PMID12402275.
Verpillat P, Ricard S, Hannequin D, et al. (2002). "Is the saitohin gene involved in neurodegenerative diseases?". Ann. Neurol. 52 (6): 829–32. doi:10.1002/ana.10384. PMID12447938.
Zekanowski C, Pepłońska B, Styczyńska M, et al. (2003). "Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia". Dementia and Geriatric Cognitive Disorders. 16 (3): 126–31. doi:10.1159/000070999. PMID12826737.
Combarros O, Rodero L, Infante J, et al. (2003). "Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer's disease". Dementia and Geriatric Cognitive Disorders. 16 (3): 132–5. doi:10.1159/000071000. PMID12826738.
de Silva R, Hope A, Pittman A, et al. (2004). "Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy". Neurology. 61 (3): 407–9. doi:10.1212/01.wnl.0000073140.25533.90. PMID12913211.
Pepłońska B, Zekanowski C, Religa D, et al. (2003). "Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population". Neurosci. Lett. 348 (3): 163–6. doi:10.1016/S0304-3940(03)00788-2. PMID12932819.
Johansson A, Zetterberg H, Håkansson A, et al. (2006). "TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease". Neuro-Degenerative Diseases. 2 (1): 28–35. doi:10.1159/000086428. PMID16909000.